Occlutech International Ab
Clinical trials sponsored by Occlutech International Ab, explained in plain language.
-
New registry tests nonsurgical plug for dangerous heart leaks
Disease control ENROLLING_BY_INVITATIONThis study follows 200 people who receive a special device to close leaks around previously implanted heart valves. The Occlutech PLD is a plug delivered through a blood vessel, avoiding open-heart surgery. Researchers will monitor safety and effectiveness for up to 3 years. The …
Sponsor: Occlutech International AB • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New device closes heart holes without surgery – but does it last?
Disease control OngoingThis study follows 50 people who received a special device to close a hole in the wall between the heart's lower chambers (a perimembranous VSD). The goal is to confirm the device works well and is safe over time, checking for serious problems like heart block or device movement.…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New heart device aims to stop repeat strokes
Disease control OngoingThis study tests a new device (Occlutech Flex II PFO Occluder) to close a common heart hole called PFO in people who have had a stroke from an unknown cause. The goal is to see if the new device works as well as standard devices at closing the hole and preventing another stroke. …
Phase: NA • Sponsor: Occlutech International AB • Aim: Disease control
Last updated May 22, 2026 13:51 UTC